Multi-Regional Clinical Trials with EU Sites: Best Practices
Multi-Regional Clinical Trials with EU Sites: Best Practices Best Practices for Conducting Multi-Regional Clinical Trials with EU Sites Multi-Regional Clinical Trials (MRCTs) are increasingly critical in global drug development, allowing sponsors to generate data that supports simultaneous regulatory submissions across multiple regions. The European Union (EU), with its harmonized regulatory framework under CTR 536/2014, plays…
Read More “Multi-Regional Clinical Trials with EU Sites: Best Practices” »